In line with our results, higher expression of ANO1 was associated with shorter OS of gastric carcinoma [9], head and neck squamous cell carcinoma [14], and esophageal squamous cell carcinoma patients [29]. Here, ANO1 is linked to esophageal squamous cell carcinoma.